Karim Sajjad, Ali Arif
Department of Bio-technology, Jamia Millia Islamia, New Delhi 110025, India.
World J Gastroenterol. 2009 Mar 21;15(11):1381-7. doi: 10.3748/wjg.15.1381.
To study the alterations in p53 gene among Indian gastric cancer patients and to correlate them with the various clinicopathological parameters.
A total of 103 gastric cancer patients were included in this study. The p53 alterations were studied by both immunohistochemical method as well as polymerase chain reaction (PCR)-single strand conformation polymorphism (SSCP) analysis. We only studied four (exon 5, 6, 7, and 8) of the 11 p53 exons. The alterations in p53 were also correlated with respect to various clinicopathological parameters.
Among 103 cases, p53 over-expression and alteration were detected in 37 (35.92%) and 19 (18.44%) cases, respectively. Most of the p53 alterations were found at exon 5 (31.54%), followed by exon 6 (26.31%), exon 7 (21.04%) and exon 8 (21.04%). A significant correlation of p53 over-expression was found with p53 alteration (P = 0.000). Concordance between p53 alteration (as detected by SSCP) and over-expression [as detected by immunohistochemistry (IHC)] was found in 75% cases. We found that IHC-positive/SSCP-negative cases accounted for 21% of cases and IHC-negative/SSCP-positive cases accounted for remaining 4% cases.
Our results show that p53 gene mutations are significantly correlated with p53 protein over-expression, with 75% concordance in over-expression and alteration in the p53 gene, but 25% disconcordance also cautions against the assumption that p53 over-expression is always associated with a gene mutation. There may be other mechanisms responsible for stabilization and accumulation of p53 protein with no evidence of gene mutation that reflect an accumulation of a non-mutated protein, or a false negative SSCP result.
研究印度胃癌患者中p53基因的改变,并将其与各种临床病理参数相关联。
本研究共纳入103例胃癌患者。通过免疫组织化学方法以及聚合酶链反应(PCR)-单链构象多态性(SSCP)分析来研究p53基因的改变。我们仅研究了11个p53外显子中的4个(外显子5、6、7和8)。p53基因的改变也与各种临床病理参数相关联。
在103例病例中,分别在37例(35.92%)和19例(18.44%)中检测到p53过表达和改变。大多数p53改变发生在外显子5(31.54%),其次是外显子6(26.31%)、外显子7(21.04%)和外显子8(21.04%)。发现p53过表达与p53改变显著相关(P = 0.000)。在75%的病例中发现p53改变(通过SSCP检测)与过表达[通过免疫组织化学(IHC)检测]之间具有一致性。我们发现IHC阳性/SSCP阴性病例占病例总数的21%,IHC阴性/SSCP阳性病例占其余的4%。
我们的结果表明,p53基因突变与p53蛋白过表达显著相关,p53基因过表达和改变的一致性为75%,但25%的不一致性也警示我们不要假定p53过表达总是与基因突变相关。可能存在其他机制导致p53蛋白的稳定和积累,而没有基因突变的证据,这反映了非突变蛋白的积累或SSCP结果的假阴性。